Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-09FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's supplemental application for INDOMETHACIN, marking an approved modification to the product under an ANDA.
-
FDA approval · 2016-05-09FDA Approved: INDOMETHACIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Indomethacin, resulting in updated labeling for the product.
-
FDA approval · 2016-05-09FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen submitted by Zameer Pharmaceuticals LLC.
-
FDA approval · 2016-04-05FDA Approved: INFLECTRA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved INFLECTRA (infliximab-dyyb) as a biosimilar to infliximab for multiple autoimmune diseases, expanding access to a biologic ther…
-
CLINICAL_TRIALS research · 2016-03-21Clinical Trial Update: Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis
This trial update compares bone cell activity between rheumatoid arthritis and ankylosing spondylitis, highlighting distinct patterns of bon…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-03-16FDA Approved: CELECOXIB — Original Application (McKesson Corporation dba SKY Packaging)
FDA approved the original Abbreviated New Drug Application for a generic celecoxib product manufactured by McKesson Corporation dba SKY Pack…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial [NA]
This randomized controlled trial evaluated whether increasing physical activity improves outcomes for people with ankylosing spondylitis. Th…
-
FDA approval · 2016-02-22FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi Aria (golimumab) from Janssen Biotech, Inc., under BLA125433, to update the product …
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis [Phase 4]
Phase 4 study evaluating the efficacy and safety of Remicade (infliximab) for early ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study [Phase 4]
This Phase 4 trial updates a switch study comparing etanercept and adalimumab in ankylosing spondylitis. The status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients [Phase 4]
A Phase 4 clinical trial assessing the cardiovascular effects of etanercept on the heart, veins, and arterial thickness in patients with ank…
-
FDA label_change · 2016-01-08FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for SIMPONI ARIA (golimumab) to update the product labeling.
-
CLINICAL_TRIALS research · 2015-12-28Clinical Trial Update: Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis [Phase 4]
Phase 4 study update investigating dose reduction of etanercept in patients with Ankylosing Spondylitis.
-
FDA approval · 2015-12-23FDA Approved: CELECOXIB — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the original application for generic celecoxib by Torrent Pharmaceuticals Limited. This marks approval of a generic version of …
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
The study evaluating golimumab in Filipino patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis has been with…
-
FDA approval · 2015-11-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis [Phase 2]
A Phase II clinical trial evaluating thalidomide for ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes [Phase 3]
Pfizer-sponsored Phase 3 trial comparing etanercept to placebo on background NSAIDs in early spondyloarthritis patients without radiographic…
-
FDA approval · 2015-09-23FDA Approved: CELECOXIB — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Celecoxib under an Original Application for generic Celecoxib. The approval covers multiple indications common…
-
CLINICAL_TRIALS trial_result · 2015-09-18Clinical Trial Update: Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis [Phase 2]
A Phase 2 double-blind, placebo-controlled trial evaluating AIN457 for efficacy in moderate to severe ankylosing spondylitis has completed, …
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab
A completed Greek clinical trial evaluated how adalimumab affects work productivity and sleep in patients with rheumatic diseases treated wi…
-
FDA approval · 2015-08-24FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen by Hikma Pharmaceuticals USA Inc., indicating changes to the product's approval.
-
FDA approval · 2015-08-21FDA Approved: CELECOXIB — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for a generic Celecoxib product. This marks the entry of a generic celecoxib into…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis [Phase 4]
Phase 4 trial comparing Celecoxib to Diclofenac in adults with ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach
This update reports the completion of a clinical trial investigating genetic susceptibility to Ankylosing Spondylitis using a functional gen…